Dr Wasan has published over 240 peer-reviewed articles and 280 abstracts in the area of lipid-based drug delivery and lipoprotein-drug interactions. He has won many prestigious awards and is a fellow of the American Association of Pharmaceutical Scientists and the Canadian Academy of Health Sciences. Most recently, Dr Wasan served as the Dean of the College of Pharmacy and Nutrition of the University of Saskatchewan (Aug 2014 – Jun 2019). Dr. Wasan is currently an Adjunct Professor and Distinguished University Scholar in the Department of Urologic Sciences, Faculty of Medicine at the University of British Columbia. He is the co-founder of the Neglected Global Diseases Initiative at UBC. Dr. Wasan led the research team at the Wasan lab at the University of British Columbia in the development of an oral formulation of amphotericin B which has successfully completed Phase I human clinical trials. He is the head of the pharmacology program at Skymount Medical.
Dr Kishor Wasan, R.PH., PhD, FAAPS, FCAHS, FCSPS: Researchers at Forefront of Fight Against COVID-19: 18Mar2021
Dr Wasan has published over 240 peer-reviewed articles and 280 abstracts in the area of lipid-based drug delivery and lipoprotein-drug interactions. He has won many prestigious awards and is a […]